David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 29,900 shares at $29.93 ($930K) on 2021-08-05, disclosed to the SEC on 2021-08-09.
Open-market sale of $930k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.93 | 6,116 | $183K | 19.7% |
| 2 | $29.93 | 6,116 | $183K | 19.7% |
| 3 | $31.03 | 2,063 | $64K | 6.9% |
| 4 | $31.03 | 2,063 | $64K | 6.9% |
| 5 | $32.15 | 6,721 | $216K | 23.2% |
| 6 | $32.15 | 6,721 |
| $216K |
| 23.2% |
| 7 | $32.63 | 100 | $3K | 0.4% |
| Total | $31.09 avg | 29,900 | $930K | 100% |
| Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |
| PRLD | SELL | 2021-05-10 | $1.2M | — | Filing → |